Director Zhu Liang of 306 reproductive center went there

He has successively studied in Guangzhou south hospital, the Third Affiliated Hospital of Peking University, the obstetrics and Gynecology Hospital of Zhejiang University, the First Affiliated Hospital of Sun Yat sen University and the Shenzhen Hospital of Peking University, and deeply cooperated with the reproctive medicine center of New York University in the United States and the reproctive medicine center of Sydney in Australia. Master the techniques of artificial insemination (IUI), in vitro fertilization (IVF-ET), ovarian hyperstimulation program selection, vaginal B-ultrasound monitoring of follicular growth, transvaginal oocyte retrieval, embryo transfer, donor and recipient cycle adjustment, etc; Master the examination and treatment of semen, intracytoplasmic sperm injection (ICSI), in vitro culture of immature eggs (IVM) and blastocyst culture, embryo freezing and thawing, sperm freezing and thawing, blastocyst vitrification, epididymal and testicular sperm treatment, laser, chemical and mechanical assisted hatching (ah), and cytoplasmic transfer, Mitochondrial transplantation and other operation techniques

Zhu Liang, general director and clinical director of reproctive medicine center of 306 hospital, associate chief physician, associate professor, postgraate supervisor, doctor of reproctive endocrinology

Participated in 973 projects and 2 projects of National Natural Science Foundation of China. More than 100 papers have been published, among which more than 30 papers have been published by the first author and more than 70 have been translated. Many papers have been adopted by the annual conference of reproctive medicine in the United States and Europe, and have been invited to speak at the annual conference of reproctive medicine in the United States and Europe and the National Conference of reproctive medicine for many times. In 2008, he was invited to be the special reviewer of human reproction, the top three Journal of reproctive medicine in the world. In 2010, he was invited to be the special editorial board of reproction and contraception, the most influential journal of reproctive medicine in China. He won two third prizes for medical achievements of the whole army. Chief editor of "clinical diagnosis and treatment of polycystic ovary syndrome", participated in editing "new progress of reproctive physiology theory and technology", "foundation and clinical of polycystic ovary syndrome", "diagnosis and treatment of infertility" and other monographs